RedHill announces compassionate use treatment with opaganib of Swiss COVID-19 patients

(RedHill Biopharma) RedHill Biopharma Ltd. (Nasdaq: RDHL) today announced that it has acted on a request to provide opaganib treatment on an outpatient basis under compassionate use exemption for several Swiss patients suffering from COVID-19 pneumonia.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news